CORTCorcept Therapeutics Inc
CORT
Corcept Therapeutics Inc4,426
Mkt Cap
$3.81BVolume
679,371.0052W High
$117.3352W Low
$28.66PE Ratio
41.55CORT Fundamentals
Price
$33.70Prev Close
$33.99Open
$33.8450D MA
$41.40Beta
1.29Avg. Volume
1.98MEPS (Annual)
$0.8182P/B
5.56Rev/Employee
$1.04M$3,809.50
Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have...
PR Newswire·1d ago
Corcept Therapeutics (NASDAQ:CORT) Insider Sells $296,305.67 in Stock
Corcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) insider William Guyer sold 8,233 shares of the firm's stock in a transaction that occurred on Wednesday, March 4th. The shares were...
MarketBeat·3d ago
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated...
PR Newswire·4d ago
William Guyer Sells 8,233 Shares of Corcept Therapeutics (NASDAQ:CORT) Stock
Corcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) insider William Guyer sold 8,233 shares of Corcept Therapeutics stock in a transaction dated Wednesday, March 4th. The shares were...
MarketBeat·4d ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT INVESTOR ALERT...
PR Newswire·5d ago
Corcept's Korlym Drives its 2025 Revenue Surge: What's Ahead?
CORT's Korlym 2025 sales rises 13% Y/Y, with 2026 revenues seen at $900M-$1B. However, the court ruling favoring Teva's generic may put pressure on future sales.
Zacks·5d ago
Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT
Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT Corcept Therapeutics Incorporated Sued for Securities Law Violations...
PR Newswire·5d ago
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated...
PR Newswire·5d ago
Law Offices of Frank R. Cruz Encourages Corcept Therapeutics Incorporated (CORT) Shareholders To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Corcept Therapeutics Incorporated (Corcept or the...
Business Wire·6d ago
Lost Money on Corcept Therapeutics Incorporated(CORT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Lost Money on Corcept Therapeutics Incorporated(CORT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky Lost Money on Corcept Therapeutics Incorporated(CORT)? Join Class Action Suit...
PR Newswire·6d ago
<
1
2
...
>